Annovis Bio Statistics Share Statistics Annovis Bio has 19.49M
shares outstanding. The number of shares has increased by 49.27%
in one year.
Shares Outstanding 19.49M Shares Change (YoY) 49.27% Shares Change (QoQ) 0% Owned by Institutions (%) 11.97% Shares Floating 16.62M Failed to Deliver (FTD) Shares 45,510 FTD / Avg. Volume 10.26%
Short Selling Information The latest short interest is 2.46M, so 12.63% of the outstanding
shares have been sold short.
Short Interest 2.46M Short % of Shares Out 12.63% Short % of Float 14.73% Short Ratio (days to cover) 7.28
Valuation Ratios PE Ratio 0 Forward PE -1.95 PS Ratio 0 Forward PS 5 PB Ratio 6.58 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Annovis Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.59,
with a Debt / Equity ratio of 0.
Current Ratio 3.59 Quick Ratio 3.59 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.07B Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -24.57B Effective Tax Rate 99.9%
Stock Price Statistics The stock price has increased by -64.17% in the
last 52 weeks. The beta is 1.51, so Annovis Bio's
price volatility has been higher than the market average.
Beta 1.51 52-Week Price Change -64.17% 50-Day Moving Average 2.67 200-Day Moving Average 3.64 Relative Strength Index (RSI) 46.76 Average Volume (20 Days) 443,548
Income Statement
Revenue n/a Gross Profit n/a Operating Income -26.7M Net Income -24.59B EBITDA -22.74M EBIT -22.74M Earnings Per Share (EPS) -2018.5
Full Income Statement Balance Sheet The company has 10.55M in cash and 0 in
debt, giving a net cash position of 10.55M.
Cash & Cash Equivalents 10.55M Total Debt n/a Net Cash n/a Retained Earnings -134.85M Total Assets 26.74M Working Capital 24.23M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.89B
and capital expenditures 0, giving a free cash flow of -21.89B.
Operating Cash Flow -21.89B Capital Expenditures n/a Free Cash Flow -21.89B FCF Per Share -1797.29
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
